Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Recruitment Status: Active, not recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (1.129)
1
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy : A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer : A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer : Hypofractionated Regional Nodal Irradiation Phase 2 Clinical Trial for Women With Breast Cancer - HeNRIetta
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer : Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer : Pilot Trial of Anastrozole and Palbociclib as First-Line Therapy and as Maintenance Therapy After First Line Chemotherapy in Hormone Receptor Positive, HER2-Negative Postmenopausal Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab : Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab (neoHIP)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients : Higher Dose taMOxifen in Premenopausal bREast Cancer Patients: a preoperaTive Window Trial (MORE-T Trial)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) : A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) : A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[113]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Medienart
1.129
Aufsätze
1.129
E-Artikel
1.129
E-Ressourcen
Zeitschriftentitel
1.129
ClinicalTrials.gov
Thema
1.129
610
Breast Neoplasms
Recruitment Status: Active, not recruiting
951
Study Type: Interventional
308
Phase: Phase 2
177
Study Type: Observational
147
Phase: Phase 3
140
Phase: Phase 1
122
Triple Negative Breast Neoplasms
116
Carcinoma
70
Neoplasms
64
Medical Condition: Breast Cancer
56
Phase: Phase 1, Phase 2
30
Breast Carcinoma In Situ
27
Carcinoma, Ductal, Breast
27
Lung Neoplasms
25
Carcinoma in Situ
25
Colorectal Neoplasms
23
Ovarian Neoplasms
23
Recurrence
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.109
2020-
20
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.129
Englisch
Haven't found what you're looking for?
Wird geladen...